Cargando…
Comprehensive National Inpatient Sample data reveals low but rising Pneumocystis jiroveci pneumonia risk in inflammatory bowel disease patients
BACKGROUND: There are only limited data to guide the management of infectious risk for Pneumocystis jiroveci pneumonia (PCP) in patients with inflammatory bowel disease (IBD). We evaluated the frequency of admissions for PCP among patients with IBD, as well as the temporal trend in PCP admission rat...
Autores principales: | Schwartz, Jeffrey, Stein, Daniel J., Feuerstein, Joseph D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hellenic Society of Gastroenterology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9062846/ https://www.ncbi.nlm.nih.gov/pubmed/35599933 http://dx.doi.org/10.20524/aog.2022.0713 |
Ejemplares similares
-
Pneumocystis jiroveci Pneumonia
por: Haque, Abida K., et al.
Publicado: (2008) -
The Pathogenesis and Diagnosis of Pneumocystis jiroveci Pneumonia
por: Apostolopoulou, Anna, et al.
Publicado: (2022) -
336. COVID-19 and Pneumocystis jiroveci Pneumonia
por: Saling, Christopher, et al.
Publicado: (2021) -
The cytological diagnosis of Pneumocystis jiroveci pneumonia in bronchoalveolar lavage
por: Kapatia, Gargi, et al.
Publicado: (2023) -
1024. Evaluation of Atovaquone Prescribing for Pneumocystis jiroveci Pneumonia (PJP) Prophylaxis
por: Aleissa, Muneerah, et al.
Publicado: (2019)